baclofen has been researched along with levetiracetam in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Klitgaard, H; Margineanu, DG | 1 |
| Le Strat, Y | 1 |
| Acharya, M; Kochar, A; Kumawat, BL; Sharma, C | 1 |
| Alavi, MS; Ghorbani, A; Hosseini, A; Negah, SS; Sadeghnia, HR | 1 |
1 review(s) available for baclofen and levetiracetam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for baclofen and levetiracetam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Levetiracetam has no significant gamma-aminobutyric acid-related effect on paired-pulse interaction in the dentate gyrus of rats.
Topics: Animals; Anticonvulsants; Baclofen; Bicuculline; Clonazepam; Convulsants; Dentate Gyrus; Diazepam; Electric Stimulation; GABA Agonists; GABA Antagonists; gamma-Aminobutyric Acid; Levetiracetam; Male; Phenobarbital; Piracetam; Rats; Rats, Sprague-Dawley; Receptors, GABA; Synaptic Transmission; Time Factors | 2003 |
Levetiracetam in the treatment of alcohol dependence: toward the end of the story?
Topics: Alcoholism; Anticonvulsants; Baclofen; Double-Blind Method; GABA Agonists; Humans; Levetiracetam; Piracetam; Quality of Life; Randomized Controlled Trials as Topic | 2012 |
'Dancing eyes, dancing feet syndrome' in small cell lung carcinoma.
Topics: Baclofen; Humans; Levetiracetam; Lung; Lung Neoplasms; Male; Middle Aged; Muscle Relaxants, Central; Opsoclonus-Myoclonus Syndrome; Piracetam; Radiography; Small Cell Lung Carcinoma | 2014 |
Levetiracetam promoted rat embryonic neurogenesis via NMDA receptor-mediated mechanism in vitro.
Topics: Animals; Baclofen; Biomarkers; Cell Differentiation; Cell Proliferation; Cell Survival; Dizocilpine Maleate; Doublecortin Protein; Embryo, Mammalian; Female; Levetiracetam; Male; Nerve Tissue Proteins; Neural Stem Cells; Neurogenesis; Neurons; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Spheroids, Cellular | 2021 |